207 related articles for article (PubMed ID: 30339966)
1. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.
Veras E; Kurman RJ; Wang TL; Shih IM
Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1): Analysis in 5536 Cases Revealed Consistent Expression in Trophoblastic Tumors.
Inaguma S; Wang Z; Lasota J; Sarlomo-Rikala M; McCue PA; Ikeda H; Miettinen M
Am J Surg Pathol; 2016 Aug; 40(8):1133-42. PubMed ID: 27158757
[TBL] [Abstract][Full Text] [Related]
4. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
[TBL] [Abstract][Full Text] [Related]
5. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions.
Xue WC; Khoo US; Ngan HY; Chan KY; Ip PP; Tsao SW; Cheung AN
Int J Gynecol Pathol; 2004 Apr; 23(2):145-50. PubMed ID: 15084843
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions.
Shih IM; Kurman RJ
Int J Gynecol Pathol; 1999 Apr; 18(2):144-50. PubMed ID: 10202672
[TBL] [Abstract][Full Text] [Related]
7. GATA-3 expression in trophoblastic tissues: an immunohistochemical study of 445 cases, including diagnostic utility.
Banet N; Gown AM; Shih IeM; Kay Li Q; Roden RB; Nucci MR; Cheng L; Przybycin CG; Nasseri-Nik N; Wu LS; Netto GJ; Ronnett BM; Vang R
Am J Surg Pathol; 2015 Jan; 39(1):101-8. PubMed ID: 25188865
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
11. GATA3 expression in gestational trophoblastic tissues and tumours.
Mirkovic J; Elias K; Drapkin R; Barletta JA; Quade B; Hirsch MS
Histopathology; 2015 Nov; 67(5):636-44. PubMed ID: 25753145
[TBL] [Abstract][Full Text] [Related]
12. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
[TBL] [Abstract][Full Text] [Related]
13. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations.
Shih IM; Kurman RJ
Am J Surg Pathol; 2004 Sep; 28(9):1177-83. PubMed ID: 15316317
[TBL] [Abstract][Full Text] [Related]
14. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases.
Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS
Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121
[TBL] [Abstract][Full Text] [Related]
15. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
[TBL] [Abstract][Full Text] [Related]
16. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
17. Expression pattern of the cell cycle promoter cyclin e in benign extravillous trophoblast and gestational trophoblastic lesions: correlation with expression of Ki-67.
Bamberger AM; Aupers S; Milde-Langosch K; Löning T
Int J Gynecol Pathol; 2003 Apr; 22(2):156-61. PubMed ID: 12649670
[TBL] [Abstract][Full Text] [Related]
18. Whole transcriptome analysis of gestational trophoblastic neoplasms reveals altered PI3K signaling pathway in epithelioid trophoblastic tumor.
Cho EJ; Chun SM; Park H; Sung CO; Kim KR
Gynecol Oncol; 2020 Apr; 157(1):151-160. PubMed ID: 31954539
[TBL] [Abstract][Full Text] [Related]
19. Detection of the alpha-subunit of inhibin in trophoblastic neoplasia.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Hum Pathol; 1999 Jan; 30(1):26-31. PubMed ID: 9923923
[TBL] [Abstract][Full Text] [Related]
20. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.
Singer G; Kurman RJ; McMaster MT; Shih IeM
Am J Surg Pathol; 2002 Jul; 26(7):914-20. PubMed ID: 12131159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
